Janet S. Macpherson

1.0k total citations
30 papers, 861 citations indexed

About

Janet S. Macpherson is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Janet S. Macpherson has authored 30 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Janet S. Macpherson's work include Cancer therapeutics and mechanisms (12 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Janet S. Macpherson is often cited by papers focused on Cancer therapeutics and mechanisms (12 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Janet S. Macpherson collaborates with scholars based in United Kingdom, United States and Australia. Janet S. Macpherson's co-authors include John F. Smyth, Duncan I. Jodrell, John E. T. Corrie, Jeffrey L. Cummings, Richard L. Hayward, W A Ratcliffe, C. Roland Wolf, Jeff Cummings, Brett P. Monia and W. M. Hunter and has published in prestigious journals such as Analytical Biochemistry, The American Journal of Human Genetics and Journal of neurosurgery.

In The Last Decade

Janet S. Macpherson

30 papers receiving 832 citations

Peers

Countries citing papers authored by Janet S. Macpherson

Since Specialization

Citations

This map shows the geographic impact of Janet S. Macpherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet S. Macpherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet S. Macpherson more than expected).

Fields of papers citing papers by Janet S. Macpherson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet S. Macpherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet S. Macpherson. The network helps show where Janet S. Macpherson may publish in the future.

Co-authorship network of co-authors of Janet S. Macpherson

This figure shows the co-authorship network connecting the top 25 collaborators of Janet S. Macpherson. A scholar is included among the top collaborators of Janet S. Macpherson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet S. Macpherson. Janet S. Macpherson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity 2008 ·European Journal of Cancer ·Sylvie M. Guichard, Janet S. Macpherson, (unknown), (unknown), Morwenna Muir, Michael Dodds, Susan Alexander, Duncan I. Jodrell	14
2	Short hairpin RNAs targeting Bcl-xL modulate senescence and apoptosis following SN-38 and irinotecan exposure in a colon cancer model 2007 ·Cancer Chemotherapy and Pharmacology ·Sylvie M. Guichard, (unknown), Pengcheng Kang, Janet S. Macpherson, Duncan I. Jodrell	7
3	ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136 2007 ·The Pharmacogenomics Journal ·Rhona Aird, Marian Thomson, Janet S. Macpherson, David E. Thurston, Duncan I. Jodrell, Sylvie M. Guichard	6
4	Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175 2005 ·Cancer Chemotherapy and Pharmacology ·Richard L. Hayward, (unknown), (unknown), Janet S. Macpherson, Rhona Aird, Sylvie M. Guichard, Abraha Habtemariam, Peter J. Sadler, Duncan I. Jodrell	68
5	Validation of real-time reverse-transcription-polymerase chain reaction for quantification of capecitabine-metabolizing enzymes 2005 ·Analytical Biochemistry ·Janet S. Macpherson, Duncan I. Jodrell, Sylvie M. Guichard	5
6	Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136 2005 ·European Journal of Cancer ·Sylvie M. Guichard, Janet S. Macpherson, David E. Thurston, Duncan I. Jodrell	15
7	Genetic Evidence for Interaction of the 5q31 Cytokine Locus and the CARD15 Gene in Crohn Disease 2003 ·The American Journal of Human Genetics ·Muddassar M. Mirza, Sheila Fisher, Kathy King, Andrew Cuthbert, Jochen Hampe, Jeremy Sanderson, John Mansfield, Peter T. Donaldson, Janet S. Macpherson, Alastair Forbes, Stefan Schreiber, Cathryn M. Lewis, Christopher G. Mathew	82
8	Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives. 2003 ·PubMed ·Jeffrey L. Cummings, Brian Ethell, Lesley Jardine, Gary W. Boyd, Janet S. Macpherson, Brian Burchell, John F. Smyth, Duncan I. Jodrell	70
9	Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. 2003 ·PubMed ·Richard L. Hayward, Janet S. Macpherson, Jeff Cummings, Brett P. Monia, John F. Smyth, Duncan I. Jodrell	56
10	Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidation 2002 ·Biochemical Pharmacology ·Jeffrey L. Cummings, Gary W. Boyd, Brian Ethell, Janet S. Macpherson, Brian Burchell, John F. Smyth, Duncan I. Jodrell	48
11	Cell cycle effects of the novel topoisomerase I inhibitor NU/ICRF 505 in a panel of chinese hamster ovary cell lines 1997 ·European Journal of Cancer ·Janet S. Macpherson, Jeffrey L. Cummings, (unknown), Eric P. Miller, J F Smyth	5
12	Determination of the novel topoisomerase I inhibitor NU/ICRF 505 and its major metabolite in plasma, tissue and tumour by high-performance liquid chromatography 1996 ·Journal of Chromatography B Biomedical Sciences and Applications ·Jeffrey L. Cummings, (unknown), Janet S. Macpherson, John F. Smyth	5
13	Accumulation of anthracenyl-amino acid topoisomerase I and II inhibitors in drug-sensitive and drug-resistant human ovarian cancer cell lines determined by high-performance liquid chromatography 1995 ·Cancer Chemotherapy and Pharmacology ·Jeffrey L. Cummings, (unknown), Janet S. Macpherson, John F. Smyth	11
14	Biochemistry of topoisomerase I and II inhibition by anthracenyl-amino acid conjugates 1995 ·Biochemical Pharmacology ·(unknown), Jeffrey L. Cummings, Janet S. Macpherson, John A. Hadfield, John F. Smyth	18
15	Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU / ICRF 500 1995 ·Mutation Research/Genetic Toxicology ·Jeffrey L. Cummings, A. T. Sumner, Anne Slavotinek, (unknown), Janet S. Macpherson, John F. Smyth	14
16	A PHARMACOKINETIC STUDY OF HIGH-DOSE METOCLOPRAMIDE SUPPOSITORIES 1990 ·Journal of Clinical Pharmacy and Therapeutics ·(unknown), (unknown), Janet S. Macpherson, (unknown), (unknown), John F. Smyth	3
17	The disposition of TCNU (tauromustine) in human malignant glioma: pharmacokinetic studies and clinical implications 1990 ·Journal of neurosurgery ·Ian R. Whittle, Janet S. Macpherson, J. Douglas Miller, John F. Smyth	11
18	Pharmacokinetics of tauromustine in cancer patients 1989 ·Cancer Chemotherapy and Pharmacology ·P. O. Gunnarsson, Jette Vibe-Petersen, Janet S. Macpherson, (unknown), (unknown), M H Ellman, Heine H. Hansen, John F. Smyth	10
19	Phase I study of TCNU, a novel nitrosourea 1987 ·European Journal of Cancer and Clinical Oncology ·John F. Smyth, Janet S. Macpherson, (unknown), Martin Kerr, (unknown), M A Cornbleet, Renaud Léonard	18
20	The clinical pharmacology of mitozantrone 1986 ·Cancer Chemotherapy and Pharmacology ·(unknown), Janet S. Macpherson, (unknown), (unknown), C. Roland Wolf	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact